Low Price Pharma Stocks List – Pharma Penny Stocks India

The table below shows the Low Price Pharma Stocks List – Pharma Penny Stocks India based on the Highest Market Capitalization.

Best Low Price Pharma Stocks

The table below shows the Best Low Price Pharma Stocks based on 1 Year Return.

Low Price Pharma Stocks Nse

The table below shows Low Price Pharma Stocks Nse based on 1 Month Return.

Low Price Pharma Stocks

The table below shows Pharma Penny Stocks based on the Highest Daily Volume.

Low Price Pharma Stocks India

The table below shows Pharma Penny Stocks India based on the PE Ratio.

Low Price Pharma Stocks Under 10 Rs

The table below shows Pharma Penny Stocks Under 10 Rs.

Low Price Pharma Stocks List – FAQs

1. Which are the Best Pharma Stocks?

• Best Pharma Stocks #1: Wanbury Ltd
• Best Pharma Stocks #2: SMS Pharmaceuticals Ltd
• Best Pharma Stocks #3: Piramal Pharma Ltd
• Best Pharma Stocks #4: Morepen Laboratories Ltd
• Best Pharma Stocks #5: Syncom Formulations (India) Ltd

The stocks mentioned are ranked according to their one-year performance.

2. Is it good to invest in Pharma Penny Stocks?

Investing in pharmaceutical penny stocks carries a high risk due to volatility, limited liquidity, and uncertainty. It’s crucial to research thoroughly, consider your risk tolerance, and diversify your portfolio wisely.

3. What are the Low Price NSE Pharma Stocks?

Pharmaceutical stocks encompass companies researching, developing, manufacturing, and distributing drugs and healthcare products. A stock price below 50 Rs may be considered “low-priced” in this sector, but it’s essential to evaluate such stocks based on various factors before investing.

4. What is the future of Pharma Penny Stocks?

The future of Pharma Penny Stocks is uncertain and highly speculative, influenced by regulatory changes, drug developments, and market sentiment. Potential investors should exercise caution and conduct thorough research before investing.

Introduction to Low Price Pharma Stocks List

Low Price Pharma Stocks List – Highest Market Capitalization

Piramal Pharma Ltd

The Market Cap of Piramal Pharma Ltd is Rs. 34,929.22 crores. The stock’s monthly return is -5.41%. Its one-year return is 114.07%. The stock is 16.34% away from its 52-week high.

Piramal Pharma Ltd is a global pharmaceutical company that provides a wide range of services, including drug discovery, development, and manufacturing. The company specializes in a diverse range of therapeutic areas such as oncology, ophthalmology, and critical care. Piramal Pharma’s global footprint spans across several countries, and it is recognized for its strong focus on R&D, innovative solutions, and high-quality standards. With a commitment to expanding its global reach, Piramal Pharma aims to make a significant impact in the healthcare industry.

Sun Pharma Advanced Research Co Ltd

The Market Cap of Sun Pharma Advanced Research Co Ltd is Rs. 7,121.95 crores. The stock’s monthly return is 0.35%. Its one-year return is -20.46%. The stock is 115.44% away from its 52-week high.

Sun Pharma Advanced Research Company (SPARC) is part of the Sun Pharmaceutical Industries group, a global leader in the pharmaceutical sector. SPARC primarily focuses on discovering and developing innovative pharmaceutical products, with special attention to specialty generics, novel drug delivery systems, and biotechnology. The company operates with a vision to expand its portfolio and contribute to improving the global healthcare system. Over the years, SPARC has developed a robust pipeline of products and collaborations with other pharmaceutical leaders.

SeQuent Scientific Ltd

The Market Cap of SeQuent Scientific Ltd is Rs. 5,088.50 crores. The stock’s monthly return is 0.94%. Its one-year return is 60.4%. The stock is 18.2% away from its 52-week high.

SeQuent Scientific Ltd is a leading global animal health company that focuses on providing high-quality pharmaceutical products for both companion and livestock animals. The company manufactures a broad range of veterinary medicines and nutraceuticals. With a strong emphasis on R&D, SeQuent Scientific has developed several innovative products that help improve animal health across different regions of the world. The company has a significant international presence and continues to build its portfolio of products to serve the growing animal healthcare market.

Best Low Price Pharma Stocks – 1 Year Return

Wanbury Ltd

The Market Cap of Wanbury Ltd is Rs. 871.66 crores. The stock’s monthly return is 13.4%. Its one-year return is 138.79%. The stock is 6.62% away from its 52-week high.

Wanbury Ltd is a prominent player in the pharmaceutical industry with a focus on high-quality generics and APIs. The company manufactures a variety of products including those used in the treatment of cardiovascular diseases, pain management, and anti-diabetic therapies. Wanbury has a strong R&D team dedicated to developing new molecules and formulations to meet the growing demand for affordable healthcare worldwide. With a strong presence in international markets, Wanbury’s commitment to high standards of production and customer satisfaction has made it a trusted name in the global pharmaceutical sector.

SMS Pharmaceuticals Ltd

The Market Cap of SMS Pharmaceuticals Ltd is Rs. 2,221.69 crores. The stock’s monthly return is -13.87%. Its one-year return is 117.58%. The stock is 51.65% away from its 52-week high.

SMS Pharmaceuticals Ltd is a pharmaceutical manufacturer that specializes in the production of APIs and finished dosage forms. The company is known for its high-quality products used in various therapeutic categories such as antibiotics, anti-inflammatory drugs, and cardiovascular medications. SMS Pharmaceuticals has made significant strides in establishing its global presence and supplying pharmaceutical products to over 30 countries. The company continues to focus on expanding its R&D capabilities and enhancing its production capacity to meet global demands.

Morepen Laboratories Ltd

The Market Cap of Morepen Laboratories Ltd is Rs. 4,731.58 crores. The stock’s monthly return is 6.78%. Its one-year return is 90.92%. The stock is 16.85% away from its 52-week high.

Morepen Laboratories Ltd is a leading pharmaceutical company that operates in the manufacturing of APIs and finished formulations. The company specializes in producing high-quality products in therapeutic areas such as anti-cold, anti-cough, pain management, and anti-diabetic drugs. Morepen is known for its strong presence in the domestic and international markets, with a significant export base in over 50 countries. The company continues to focus on innovation and quality, with a research-driven approach to meet the healthcare needs of global consumers.

Low Price Pharma Stocks Nse – 1 Month Return

Bliss GVS Pharma Ltd

The Market Cap of Bliss GVS Pharma Ltd is Rs. 1,695.11 crores. The stock’s monthly return is 28.99%. Its one-year return is 15.58%. The stock is 7.14% away from its 52-week high.

Bliss GVS Pharma Ltd is an established pharmaceutical company that manufactures and markets a wide range of over-the-counter products, including cough syrups, pain relievers, and vitamins. The company’s products are widely available in domestic and international markets. Bliss GVS Pharma’s commitment to quality and affordable healthcare has led to a strong presence in the global market, particularly in emerging economies. The company continually invests in new product development and research to expand its portfolio of products across various therapeutic areas.

Themis Medicare Ltd

The Market Cap of Themis Medicare Ltd is Rs. 2,635.11 crores. The stock’s monthly return is 11.71%. Its one-year return is 62.77%. The stock is 8.04% away from its 52-week high.

Themis Medicare Ltd is a leading pharmaceutical company that focuses on the development, manufacturing, and marketing of high-quality medicines across various therapeutic categories. The company specializes in vaccines, immunological products, and other pharmaceutical formulations.

Lyka Labs Ltd

The Market Cap of Lyka Labs Ltd is Rs. 587.49 crores. The stock’s monthly return is 11.64%. Its one-year return is 30.38%. The stock is 4.79% away from its 52-week high.

Lyka Labs Ltd is a well-established pharmaceutical company known for its expertise in manufacturing and marketing pharmaceutical products across various therapeutic categories, including dermatology, pain management, and anti-infective therapies. With a strong research and development foundation, Lyka Labs continues to focus on quality and innovation to meet global healthcare demands. The company has expanded its reach to international markets and remains committed to improving health outcomes through its wide range of offerings in both generic and branded formulations.

Pharma Penny Stocks – Highest Day Volume

Syncom Formulations (India) Ltd

The Market Cap of Syncom Formulations (India) Ltd is Rs. 2,070.82 crores. The stock’s monthly return is 4.55%. Its one-year return is 84.14%. The stock is 26.65% away from its 52-week high.

Syncom Formulations (India) Ltd is a pharmaceutical company involved in the manufacturing and marketing of APIs and finished dosage forms. Syncom has a significant presence in various international markets, and its products are well-regarded for their quality and affordability. The company’s offerings cover multiple therapeutic segments, including pain management, anti-inflammatory drugs, and anti-infective therapies. Syncom’s commitment to high standards of production and continuous innovation has helped it expand its global market reach.

Alembic Ltd

The Market Cap of Alembic Ltd is Rs. 3,518.94 crores. The stock’s monthly return is 3.92%. Its one-year return is 57.64%. The stock is 23.32% away from its 52-week high.

Alembic Ltd is a leading pharmaceutical and biotechnology company that has been serving the global healthcare market for over a century. It offers a broad range of products, including formulations, APIs, and biotechnology solutions. Alembic has a strong research and development division that focuses on innovative solutions to address a variety of medical needs. The company has a global footprint with a presence in more than 85 countries. Alembic’s growth is fueled by its strategic approach to partnerships and focus on advanced technologies in both generic and branded drugs.

Kopran Ltd

The Market Cap of Kopran Ltd is Rs. 1,036.01 crores. The stock’s monthly return is -26.43%. Its one-year return is -17.21%. The stock is 72.18% away from its 52-week high.

Kopran Ltd is a pharmaceutical company engaged in the manufacturing of active pharmaceutical ingredients and formulations. The company offers a wide range of products across therapeutic categories like cardiovascular, anti-diabetic, and antibiotics. Kopran has a global presence and is known for its emphasis on quality and cost-effective solutions. With a strong foundation in research and development, the company continues to expand its product offerings and improve its market position.

Pharma Penny Stocks India – PE Ratio

Ind Swift Ltd

The Market Cap of IND Swift Laboratories Ltd is Rs. 585.79 crores. The stock’s monthly return is -19.65%. Its one-year return is 2.19%. The stock is 87.61% away from its 52-week high.

IND Swift Laboratories Ltd is a prominent pharmaceutical company that focuses on manufacturing high-quality pharmaceutical formulations for both domestic and international markets. The company specializes in the production of oral solid dosage forms, liquid orals, and injectables. With over two decades of experience, IND Swift Laboratories has established itself as a key player in the global pharmaceutical industry. It has a significant presence in markets such as Europe, Africa, and the Middle East.

Accent Microcell Ltd

The Market Cap of Accent Microcell Ltd is Rs. 545.01 crores. The stock’s monthly return is -0.62%. Its one-year return is -18.95%. The stock is 40.54% away from its 52-week high.

Accent Microcell Ltd is a pharmaceutical company that specializes in the development, manufacturing, and marketing of active pharmaceutical ingredients (APIs) and formulations. The company has a strong emphasis on research and development to meet the needs of global markets. Accent Microcell’s products are widely used across various therapeutic segments, including cardiovascular, anti-diabetic, and anti-inflammatory treatments. With years of industry experience, the company is committed to providing high-quality products that comply with international standards.

Anuh Pharma Ltd

The Market Cap of Anuh Pharma Ltd is Rs. 1,084.67 crores. The stock’s monthly return is 7.92%. Its one-year return is 35.71%. The stock is 22.12% away from its 52-week high.

Anuh Pharma Ltd is a well-established pharmaceutical company known for its expertise in the production of APIs and formulations. The company offers a wide range of products across various therapeutic categories such as anti-infective, anti-inflammatory, and analgesic drugs. Anuh Pharma’s commitment to high standards in quality control and continuous research has allowed it to maintain a strong position in the market. Its products are exported to over 30 countries worldwide, making it a significant player in the international pharmaceutical market.

We hope you’re clear on the topic, but there’s more to explore in stocks, commodities, mutual funds, and related areas. Here are important topics to learn about.

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.